Carlos de Mestral
Overview
Explore the profile of Carlos de Mestral including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Mestral C, Piumatti G, Nehme M, Guessous I, Stringhini S
Prev Med Rep
. 2024 Jul;
45:102823.
PMID: 39081844
Objective: We assessed trends in socioeconomic inequalities in cardiovascular risk factors prevalence among Swiss adults from 2008 to 2019. Methods: Using data from the Bus Santé study, an annual survey...
2.
Pauli A, de Mestral C, Marques-Vidal P
Sci Rep
. 2024 Feb;
14(1):4839.
PMID: 38418618
Diabetes is increasing in Switzerland, but whether its management has improved is unknown. We aimed to assess diabetes prevalence, diagnosis, treatment, and control in French-speaking Switzerland. Our study used cross-sectional...
3.
Marques-Vidal P, Chekanova V, de Mestral C, Guessous I, Stringhini S
Int J Cardiol Cardiovasc Risk Prev
. 2023 May;
18:200187.
PMID: 37250185
We assessed 1) trends in prevalence, awareness, treatment and control rates of dyslipidaemia and associated factors, 2) the effect of statin generation/potency on control levels and 3) the effect of...
4.
Baysson H, Pullen N, de Mestral C, Semaani C, Pennacchio F, Zaballa M, et al.
Swiss Med Wkly
. 2023 Apr;
153(4):40049.
PMID: 37011595
Objective: We aimed to examine factors associated with parental willingness to vaccinate their children against COVID-19. Methods: We surveyed adults included in a digital longitudinal cohort study composed of participants...
5.
Zaballa M, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, et al.
Lancet Reg Health Eur
. 2022 Dec;
24:100547.
PMID: 36474728
Background: More than two years into the COVID-19 pandemic, most of the population has developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public health decision-making is hindered by the lack...
6.
Dumont R, Nehme M, Lorthe E, de Mestral C, Richard V, Baysson H, et al.
BMJ Open
. 2022 Nov;
12(11):e063504.
PMID: 36410813
Objectives: To estimate the prevalence of children and adolescents reporting persistent symptoms after SARS-CoV-2 infection. Design: A random sample of children and adolescents participated with their family members to a...
7.
Menon L, Richard V, de Mestral C, Baysson H, Wisniak A, Guessous I, et al.
Prev Med
. 2022 Feb;
156:106987.
PMID: 35150752
Background: Health systems around the world continue to navigate through operational challenges surfaced by the coronavirus disease 2019 (COVID-19) pandemic; these have implications for access to healthcare. In this study,...
8.
Stringhini S, Zaballa M, Pullen N, Perez-Saez J, de Mestral C, Loizeau A, et al.
Euro Surveill
. 2021 Oct;
26(43).
PMID: 34713799
BackgroundUp-to-date seroprevalence estimates are critical to describe the SARS-CoV-2 immune landscape and to guide public health decisions.AimWe estimate seroprevalence of anti-SARS-CoV-2 antibodies 15 months into the COVID-19 pandemic and 6...
9.
Stringhini S, Zaballa M, Pullen N, de Mestral C, Perez-Saez J, Dumont R, et al.
Nat Commun
. 2021 Jun;
12(1):3455.
PMID: 34103517
Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we...
10.
Stringhini S, Zaballa M, Perez-Saez J, Pullen N, de Mestral C, Picazio A, et al.
Lancet Infect Dis
. 2021 Feb;
21(5):600-601.
PMID: 33539733
No abstract available.